ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Publication Date: 1992-08-07
    Description: Antigen-specific T cell activation depends on T cell receptor-ligand interaction and costimulatory signals generated when accessory molecules bind to their ligands, such as CD28 to the B7 (also called BB1) molecule. A soluble fusion protein of human CTLA-4 (a protein homologous to CD28) and the immunoglobulin (lg) G1 Fc region (CTLA4lg) binds to human and murine B7 with high avidity and blocks T cell activation in vitro. CTLA4lg therapy blocked human pancreatic islet rejection in mice by directly affecting T cell recognition of B7+ antigen-presenting cells. In addition, CTLA4lg induced long-term, donor-specific tolerance, which may have applications to human organ transplantation.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Lenschow, D J -- Zeng, Y -- Thistlethwaite, J R -- Montag, A -- Brady, W -- Gibson, M G -- Linsley, P S -- Bluestone, J A -- AI29531/AI/NIAID NIH HHS/ -- R29 DK40092/DK/NIDDK NIH HHS/ -- New York, N.Y. -- Science. 1992 Aug 7;257(5071):789-92.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Ben May Institute, University of Chicago, IL 60637.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/1323143" target="_blank"〉PubMed〈/a〉
    Keywords: Abatacept ; Animals ; Antibodies, Monoclonal/therapeutic use ; Antigens, CD ; Antigens, Differentiation/immunology/*therapeutic use ; CTLA-4 Antigen ; Diabetes Mellitus, Experimental/*surgery ; Graft Survival/*immunology/physiology ; Humans ; *Immunoconjugates ; Immunoglobulin Fc Fragments ; Immunoglobulin G ; Immunosuppressive Agents/*therapeutic use ; Islets of Langerhans Transplantation/*immunology/physiology ; Mice ; Mice, Inbred Strains ; Phosphates/analysis/*metabolism ; Receptors, Cell Surface/immunology ; Recombinant Fusion Proteins/*therapeutic use ; Time Factors ; Transplantation, Heterologous/*immunology/physiology ; Uranium/analysis/*metabolism ; *Uranium Compounds
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...